Article Versions Notes

Xing L, Xu X, Xu W, Liu Z, Shen X, Zhou J, Xu L, Pu J, Yang C, Huang Y, et al. A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern. Viruses. 2022; 14(3):597. https://doi.org/10.3390/v14030597

Xing, Lixiao, Xinfeng Xu, Wei Xu, Zezhong Liu, Xin Shen, Jie Zhou, Ling Xu, Jing Pu, Chan Yang, Yuan Huang, and et al. 2022. "A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern" Viruses 14, no. 3: 597. https://doi.org/10.3390/v14030597

Xing, L., Xu, X., Xu, W., Liu, Z., Shen, X., Zhou, J., Xu, L., Pu, J., Yang, C., Huang, Y., Lu, L., Jiang, S., & Liu, S. (2022). A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern. Viruses, 14(3), 597. https://doi.org/10.3390/v14030597